Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) derived from anthranilic acid that functions as a dual inhibitor of cyclooxygenase enzymes, COX-1 and COX-2, to reduce prostaglandin synthesis.… Read more
Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) derived from anthranilic acid that functions as a dual inhibitor of cyclooxygenase enzymes, COX-1 and COX-2, to reduce prostaglandin synthesis. Clinically, it is primarily indicated for the management of mild to moderate pain, including the treatment of primary dysmenorrhea. This category provides access to high-quality reference standards, including stable isotope labelled compounds like Mefenamic Acid-d3 and its associated metabolites such as Mefenamic-d3 Acyl-β-D-glucuronide. These materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control testing of the active pharmaceutical ingredient. By utilizing these labelled internal standards and impurity reference materials, analytical chemists can ensure precise quantification and accurate identification in complex biological matrices, facilitating compliance with regulatory pharmacopeial standards throughout the drug development and manufacturing lifecycle.